Cancer research
Scientists at Ankara University in Turkey have made significant strides in understanding the complexities of colorectal cancer (CRC) through a comprehensive study that has identified four key genes involved in CRC pathology and development. The groundbreaking research, published in the PeerJ journal, aimed to develop a model for prognosis prediction
Cancer research
The UNC Lineberger Comprehensive Cancer Center is conducting the Vanguard Study, a national study of a new type of blood test that screens for several types of cancer. The study aims to evaluate whether Multi-Cancer Detection (MCD) tests can help people between the ages of 45 and 75 find cancer
Cancer research
The global liquid biopsy market is projected to undergo significant transformation in the coming years, driven by the increasing prevalence of cancer, adoption of minimally invasive diagnostic tests, and advances in biomarker discovery. The market is expected to grow from USD 11.41 Billion in 2024 to USD 30.65
Cancer research
Researchers from the Department of ECE have successfully integrated LightGBM with SHAP within a federated learning framework to enhance cancer detection in medical imaging. This innovative approach achieved a remarkable accuracy of 98.3% in cancer detection, with precision, recall, and F1 scores of 97.8%, 97.2%, and 95%
Cancer research
The global non-small cell lung cancer (NSCLC) treatment market is experiencing significant growth, driven by advancements in immunotherapies, targeted therapies, and a rising global incidence of lung cancer. Innovations in immune checkpoint inhibitors, such as pembrolizumab and nivolumab, have revolutionized the treatment landscape by offering improved survival rates, particularly in
Cancer research
Researchers at the Wistar Institute have made a groundbreaking discovery that could potentially lead to a new therapeutic target for ovarian and other cancers. By targeting a specific cleft in the retinoblastoma protein, scientists were able to kill tumor-protecting macrophages, making the tumor cells more vulnerable to immune attack. This
Cancer research
Researchers at the University of California, Irvine have made a significant breakthrough in rectal cancer treatment. According to a phase II trial, short-course radiation therapy (SC RT) followed by three months of trifluridine/tipiracil (FTD/TPI) plus oxaliplatin (TASOX) chemotherapy has shown promising results in treating intermediate-risk rectal cancer. The
Cancer research
A new clinical trial at Sunnybrook Health Sciences Centre aims to study the effectiveness of a combined radiation therapy approach for patients with large brain tumors. The trial, which is currently recruiting participants, will investigate the use of the Gamma Knife and a linear accelerator to deliver precise radiation therapy
Cancer research
Research from the American University of Beirut has highlighted the potential of melittin-based nanoparticles in cancer therapy, citing their ability to target cancer cells while minimizing side effects. The study, published in Pharmaceutics, provides a comprehensive overview of the mechanisms through which melittin exerts its anticancer effects and evaluates the
Cancer research
A team of researchers from Nankai University has made a significant breakthrough in the fight against oral squamous cell carcinoma (OSCC), a type of oral cancer. Through a comprehensive CRISPR/Cas9 library screening, they identified Suppressor of variegation 3-9 homolog 2 (SUV39H2), a histone methyltransferase, as a critical factor in
Cancer research
Researchers from Shenyang Pharmaceutical University have made a significant discovery in the field of cancer gene therapy, developing a novel hyaluronic acid (HA)-modified epigallocatechin gallate (EGCG)-loaded liposome that enhances stability and anticancer efficacy against A549 cells. The study, published in Carbohydrate Polymer Technologies and Applications, found that the
Cancer research
A recent study conducted by Tehran University of Medical Sciences has shed light on the effects of radiotherapy on immune activation in rectal cancer patients. The research retrospectively assessed patients treated with neoadjuvant radiotherapy between 2019 and 2021, with a focus on the impact of long-course (LCRT) and short-course (SCRT)
